Literature DB >> 34493244

The impact of the COVID-19 pandemic on Sexually Transmitted Infections surveillance data: incidence drop or artefact?

Alexis Sentís1,2,3,4, Albert Prats-Uribe5, Evelin López-Corbeto1,2, Marcos Montoro-Fernandez1, Daniel Kwakye Nomah1,6, Patrícia Garcia de Olalla2,7, Lilas Mercuriali7, Núria Borrell8, Víctor Guadalupe-Fernández9, Juliana Reyes-Urueña10,11, Jordi Casabona1,2,6.   

Abstract

BACKGROUND: Before the COVID-19 pandemic, Sexually transmitted infections (STIs) were increasing in Europe, and Spain and Catalonia were not an exception. Catalonia has been one of the regions with the highest number of COVID-19 confirmed cases in Spain. The objective of this study was to estimate the magnitude of the decline, due to the COVID-19 pandemic, in the number of STI confirmed cases in Catalonia during the lockdown and de-escalation phases.
METHODS: Interrupted time series analysis was performed to estimate the magnitude of decline in the number of STI reported confirmed cases - chlamydia, gonorrhoea, syphilis, and lymphogranuloma venereum- in Catalonia since lockdown with historical data, from March 13th to August 1st 2020, comparing the observed with the expected values.
RESULTS: We found that since the start of COVID-19 pandemic the number of STI reported cases was 51% less than expected, reaching an average of 56% during lockdown (50% and 45% during de-escalation and new normality) with a maximum decrease of 72% for chlamydia and minimum of 22% for syphilis. Our results indicate that fewer STIs were reported in females, people living in more deprived areas, people with no previous STI episodes during the last three years, and in the HIV negative.
CONCLUSIONS: The STI notification sharp decline was maintained almost five months after lockdown started, well into the new normality. This fact can hardly be explained without significant underdiagnosis and underreporting. There is an urgent need to strengthen STI/HIV diagnostic programs and services, as well as surveillance, as the pandemic could be concealing the real size of the already described re-emergence of STIs in most of the European countries.
© 2021. The Author(s).

Entities:  

Keywords:  COVID-19; Epidemiology; Interrupted time series; Lockdown; Public health; Sexually transmitted infections; Surveillance, communicable diseases; Trends

Mesh:

Year:  2021        PMID: 34493244      PMCID: PMC8423330          DOI: 10.1186/s12889-021-11630-x

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


Background

Before the coronavirus disease 2019 (COVID-19) pandemic, the number of new cases of mandatory notifiable sexually transmitted infections (STIs) was increasing in many European countries. Catalonia also had a pronounced rise of chlamydia, gonorrhoea, syphilis and lymphogranuloma venereum (LGV). For the last five years, Catalonia presented the highest incidence rates of Spain in all mandatory notifiable STIs, with a 20% annual increase. The rates were highest among males who have sex with males (MSM) and young adults, mostly females aged between 20 to 24 [1]. STIs represent one of the highest burdens of disease in adolescents and young females, leading to miscarriage, pelvic inflammatory disease, and increased risk to acquire human immunodeficiency virus (HIV) [2-4]. According to data published by the Government of Catalonia, the COVID-19 pandemic hit Catalonia harshly, with 676.863 confirmed cases and 22.124 deaths by May 24th, 2021, with one of the highest number of confirmed cases in Spain [5, 6]. On March 13, the Spanish government announced a countrywide lockdown, with a mandatory stay at home ordinance, with some exceptions, such as purchasing food or medicine, going to work or attending to emergencies. Visiting intimate partners were not included in the exceptions [7]. The combined effects of the lockdown and the unprecedented pressure on health systems might have reduced the capacity to detect STIs, potentially leading to increased transmission and more severe sequelae, or a decrease in the incidence because of less exposure. The objective of this study was to estimate the magnitude of the decline, due to the COVID-19 pandemic, in the number of STI reported confirmed cases in Catalonia during the lockdown and de-escalation phases comparing the observed and expected values.

Methods

The Catalan HIV/STI surveillance systems

We used epidemiological data from all STI confirmed cases reported to the Catalan HIV/STI Registry of Catalonia [8] through the Epidemiological Repository of Catalonia (REC), an electronic database that collects data reported from health care professionals and laboratories by means of standardized notification forms and epidemiological questionnaires, both electronically or in paper. According to the mandatory notification of diseases and outbreaks Catalan regulation (Health Department of Government of Catalonia article 13 of law 67/2010, 25 May 2010), nominal notification of syphilis, gonorrhoea, and LGV cases has been mandatory since 2007 and chlamydia since 2015; the notification of HIV cases was voluntary between 2001 and 2010 when it also became mandatory and nominal. The European Centre for Disease Prevention and Control (ECDC) guidelines are used for case definition criteria and all reported cases are reviewed by epidemiologists from the Epidemiological Surveillance Network of Catalonia (XVEC) to ensure completeness and validity of the data.

Study variables

Sex, age group, and country of birth were collected from REC. Deprivation index (calculated by the Agency of Health Quality and Assessment of Catalonia) was based on the patient area of residence and categorized in quintiles, with the first quintile being the least deprived [9]. Multiple episodes by the same STI in the same individual were considered reinfections when evidence of it, proper treatment, and minimum length of time between reports existed. Time periods were defined according to specific STI treatment duration and follow up recommendations, being 364, 29, 119 and 119 days respectively for syphilis, gonorrhoea, chlamydia and LGV [10]. HIV status was confirmed checking the HIV status among individuals who had one single or more STI episodes during the study period within the Catalan HIV/STI Registry of Catalonia where previous and simultaneous HIV coinfections can be identified.

Interrupted time series and data analysis

We analysed STI reported cases between August 1st 2017 and August 1st 2020 in Catalonia. We have included three years of follow-up not only in order to estimate the reported cases we would have had from lockdown - from March 13th to August 1st, 2020- but also to capture potential seasonal or cyclic changing patterns. For each of the mentioned variables, among the STI reported confirmed cases, the total number and its distribution in the respective categories were calculated, before lockdown, during lockdown (March 13th to April 27th), on de-escalation phases (April 28th until June 21st), and during the new normality phase (since June 22nd). The main objective of the de-escalation plan was to ensure maintaining the protection of public health while gradually recovering the common daily life and economic activities after the lockdown. This transition to a “new normality” was gradual, asymmetrical, and coordinated with the autonomous communities [11]. We used these dates as change points for an interrupted time series (ITS) analysis of daily STI reported cases (overall and separately for each of them). Reported cases were modelled as autoregressive integrated moving average (ARIMA) processes to estimate expected number of STI reported cases in each specific study period since lockdown based on pre-lockdown data. We calculated the overall drop in number of STI reported cases, to estimate the magnitude of the decline in STI reported cases with historical data comparing the observed and expected values.

Results

When comparing with pre-lockdown period’s data, the STI reported cases per day decreased by almost 50% in all three COVID-19 related study periods: during lockdown, de-escalation and new normality periods (from 43.8 STI reported cases/day pre-lockdown to 22.2, 23.4 and 27.9 respectively). The proportion of syphilis and LGV slightly increased (from 15% and 1.7% pre-lockdown) among the overall STI reported cases in all three COVID-19 related study periods (respectively in the three study periods to 16.9%, 18%, and 17.3% for syphilis and 2.8%, 2.3% and 3.1% for LGV) meanwhile gonorrhoea and chlamydia had a small decrease (from 31.9% and 51.3% pre-lockdown to 30.3% and 49.1% in the “new normality” period for gonorrhoea and for chlamydia respectively). In addition, the proportion of STI reported cases from females was reduced when compared to males (approximately 5% between pre-lockdown and new normality periods). STI reported cases that came from areas with higher socioeconomic status increased by 5% over post-lockdown periods (see Table 1). The proportion of missing data for country of birth was high during all the different study periods and increased by 25% during lockdown (from 56.7% missing values in pre-lockdown data to 84% during lockdown). The proportion of STI reported cases in people coinfected by HIV, as well as the proportions of STI reported cases considered as reinfections, increased from pre-lockdown to new normality periods (5.2% to 6.1% and 11.7% to 22.2%, respectively). The proportion of reported cases in each age groups was similar when comparing the study periods with previous or historical data (see Table 1).
Table 1

Epidemiological characteristics of the STI reported confirmed cases during the different study periodsa in Catalonia, August 1st 2017 to August 1st 2020

TotalPre-lockdownLockdownDe-escalation PhasesNew Normality
Number of reported casesN = 45,181N = 41,802N = 997N = 1266N = 1116
Days,n°reported cases/days109641.295443.84522.25423.44027.9
N%N%N%N%N%
STI
 Chlamydia23,09551.121,46351.347247.361148.354949.1
 Gonorrhoea14,40631.913,34031.932933.039831.433930.3
  LGVb8151.87231.7282.8292.3353.1
 Syphilis686515.2627615.016816.922818.019317.3
Sex
 Females17,86039.516,67939.934034.145335.838834.7
 Males27,32160.525,12360.165765.981364.272865.2
Age (mean, SDc)31.711.131.711.131.910.632.511.932.311.4
Age group
  < 20577612.8538412.911311.315412.212511.2
 20 to 2917,33438.416,05238.437637.747737.742938.4
 30 to 3912,07626.711,18026.728228.332125.429326.3
 40 to 49670214.8617714.815515.519815.617215.4
 50 to 5923345.2021245.1565.6836.6716.4
  ≥ 609592.18852.1151.5332.6262.3
Deprivation index
 First quintile11,22124.810,28824.628628.7034427.2030327.2
 Second quintile813318.0743617.821421.5024019.0024321.8
 Third quintile532911.8491511.813513.5015512.2012411.1
 Fourth quintile615013.6571713.710610.6019315.2013412.0
 Fifth quintile824618.3761818.218518.6023618.6020718.5
 Missing610213.5582813.9717.10987.701059.4
Country of birth
 Spain13,86130.713,31631.913613.620716.420218.1
 Others491310.9478511.4242.4564.4484.3
 Missing26,40758.423,70156.783784.0100379.286677.6
Reinfeccion
 No39,61987.736,89388.383884.1101980.586977.9
 Yes556212.3490911.715915.924719.524722.1
HIV status
 Negative42,80994.839,62894.893794.0119694.5104893.9
 Positive23725.221745.2606.0705.5686.1

aPre-lockdown: from August 1st 2017 to March 12th 2020, lockdown: from March 13th 2020 to April 27th2020, de-escalation phases: from April 28th 2020 to June 21st 2020, new normality: from June 22nd 2020 to August 1st 2020;

bLGV: Lymphogranuloma venereum;

cSD: Standard deviation

Epidemiological characteristics of the STI reported confirmed cases during the different study periodsa in Catalonia, August 1st 2017 to August 1st 2020 aPre-lockdown: from August 1st 2017 to March 12th 2020, lockdown: from March 13th 2020 to April 27th2020, de-escalation phases: from April 28th 2020 to June 21st 2020, new normality: from June 22nd 2020 to August 1st 2020; bLGV: Lymphogranuloma venereum; cSD: Standard deviation In the ITS (see Table 2, Fig. 1, and supplemental material, figure S1–S4), we observed how the number of all STI reported cases were only 49% of the expected number (decrease of − 51%, confidence interval (CI): − 59% to − 38%), based on pre-lockdown data (since August 1st 2020), with variations in the different study periods; being only 44% of the expected reported cases during lockdown (decrease of − 56%, CI: − 63% to − 46%) and slowly increasing to 55% of the expected since the new normality began on June 22nd (decrease of − 45%, CI: − 54% to − 30%). When analysing the results by type of infection we found that chlamydia’s reported cases which represent more than 50% of all STI reported cases, had the highest decrease in notification over post-lockdown periods, with observed reported cases reaching only 28% of the expected values. Conversely, we observed that the decrease of syphilis reported cases was lower, with observed reported cases reaching 78% of those expected (see Table 2 and supplemental material, figure S1 and figure S3).
Table 2

Comparing observed and expected number of STI reported confirmed cases during the different study periodsa in Catalonia, August 1st 2017 to August 1st 2020

Periodsobservedexpectedupper CIblower CIbdifferenceupper CIblower CIb
All STIsPre-lockdown41,814
Lockdown997226426811846− 1267−56%− 1684−63%− 849−46%
De-escalation1266254630782015− 1280−50%− 1812−59%− 749−37%
New Normality1116202624461606− 910−45%− 1330−54%− 490−30%
Total3379683682055467− 3457−51%− 4826−59%− 2088−38%
ChlamydiaPre-lockdown21,463
Lockdown472160717311483−1135−71%− 1259−73%− 1011−68%
De-escalation611237625352216− 1765−74%− 1924−76%− 1605−72%
New Normality549187019971743− 1321−71%− 1448−73%− 1194−68%
Total1632585362645442− 4221−72%− 4632−74%− 3810−70%
GonorrhoeaPre-lockdown13,340
Lockdown329747889605−418−56%−560−63%−276−46%
De-escalation3988571037678− 459−54%− 639−62%−280−41%
New Normality339670812529− 331−49%− 473− 58%−190−36%
Total1066227527381812− 1209−53%− 1672−61%− 746− 41%
SyphilisPre-lockdown6276
Lockdown168250337164−82−33%− 169−50%42%
De-escalation228284392177−56−20%− 164−42%5129%
New Normality193218302134−25−11%−109−36%5944%
Total5897531030475−164−22%− 441−43%11424%
LGVcPre-lockdown723
Lockdown28546247−26−48%−34−55%−19−40%
De-escalation29808971−51−64%−60−67%−42−59%
New Normality35566349−21−38%−28−45%−14−29%
Total92191214167−99−52%− 122−57%−75−45%

aPre-lockdown: from August 1st 2017 to March 12th 2020, lockdown: from March 13th 2020 to April 27th2020, de-escalation phases: from April 28th 2020 to June 21st 2020, new normality: from June 22nd 2020 to August 1st 2020; bCI, confidence interval; cLGV, lymphogranuloma venereum

Fig. 1

Observed and expected time series trends of daily STI reported confirmed cases in Catalonia during the COVID-19 pandemic, August 1st 2017 - August 1st 2020 (dark grey: lockdown, light grey: de-escalation phases)

Comparing observed and expected number of STI reported confirmed cases during the different study periodsa in Catalonia, August 1st 2017 to August 1st 2020 aPre-lockdown: from August 1st 2017 to March 12th 2020, lockdown: from March 13th 2020 to April 27th2020, de-escalation phases: from April 28th 2020 to June 21st 2020, new normality: from June 22nd 2020 to August 1st 2020; bCI, confidence interval; cLGV, lymphogranuloma venereum Observed and expected time series trends of daily STI reported confirmed cases in Catalonia during the COVID-19 pandemic, August 1st 2017 - August 1st 2020 (dark grey: lockdown, light grey: de-escalation phases)

Discussion

We found that since the start of COVID-19 pandemic the number of STI reported cases was 51% less than expected, reaching an average of 56% during lockdown (50 and 45% during de-escalation and new normality) with a maximum decrease of 72% for chlamydia and minimum of 22% for syphilis. Our results indicate that STIs were less reported in females, people living in more deprived areas, people with no previous STI episodes during the last three years, and without HIV infection. We hypothesize that the decline in the number of STI reported cases was higher in females based on the annual STI notification rates in the region where chlamydia has been usually higher among females and syphilis among males [1]. STIs, including chlamydia infection are predominantly asymptomatic in females, and are detected primarily through screening. During lockdown, mobility restrictions may have decreased healthcare seeking behaviour in asymptomatic individuals with high-risk exposures. This decrease could be even greater for people living in more deprived areas. Additionally, people who already visited sexual health care for previous STI episodes in the last three years, or HIV positive are more likely to seek health care. To the best of our knowledge, few analysis have described the estimated magnitude and impact of the COVID-19 pandemic on the expected number of STIs compared to the most recent historical data. Although few articles have analysed STI incidences during lockdown, some authors argue that the plausible decrease of sexually relations during the COVID-19 pandemic may partially explain the apparent drop in the number of STI incidence [12-14]. In spite of these, different stakeholders have started raising awareness about disruptions in sexual health services including STI and HIV testing and detection [15, 16]. Moreover, it has been estimated that in the Atlanta (State of Georgia, United States), if sexual behaviour rebounds while service interruption persists, cases will increase in hundreds for HIV and in thousands for STIs for the next five years [17]. Berzkalns et al. performed a study in King County (State of Washington, United States) where the number of sexual health clinic visits decreased 55% during lockdown. Although after lockdown numbers returned to pre-lockdown values, around lockdown, from January–July 2020, the number of STIs diagnosed declined differently depending on the STI, from 9% for gonorrhoea to 22% for early latent syphilis [18]. They suggested that a real decline may have happened, but the larger decline in asymptomatic STIs probably indicates decreased screening. Similarly, Chow et al. described that, although a relevant decrease in the total number of consultations occurred in the Melbourne Sexual Health Centre during the lockdown, for more severe conditions such as pelvic inflammatory disease or infectious syphilis, a similar number of consultations to the pre-lockdown period was observed [19]. Recently, an article from the EuroTEST COVID-19 impact assessment consortium described that, among 34 countries in the World Health Organization (WHO) European Region and in different testing settings, 95% of them declared to have tested less than half the expected number of people between March and May 2020, a decline that continued at lesser degrees until August 2020 [20]. Then, this decline probably is due to the effect of a combination of factors; changes in the people’s behaviour, sexual relationships or fear of visiting a health care setting [21], less available resources to diagnose and notify STIs (including human resources), and surveillance systems which were not able to integrate the immediate reaction to a pandemic, while coping with their regular surveillance activities.

Conclusions

Our results showed that the STI notification sharp decline was maintained almost five months since lockdown, well into the new normality. This can hardly be explained without significant underdiagnoses and underreporting. The gradual increase in the number of STI reported cases that we observed after lockdown may be pointing out the possibility that lockdowns did not completely disrupt STI transmission. As discussed in the present article, with the available current scientific evidence, it seems that the observed decrease in the number of STI reported cases during the current COVID-19 pandemic is probably due to a combination of factors. More research is needed in order to disentangle the specific role and relevance that has had underdiagnosis, underreporting, and the decrease in sexual risk activities and other potential factors in this decline. Finally, we truly believe that there is an urgent need to strengthen STI/HIV diagnostic programs and services, as well as surveillance, as the pandemic could be concealing the real size of the already described re-emergence of STIs [22]. Additional file 1: Fig. S1. Expected and observed time series trends of daily Chlamydia reported confirmed cases in Catalonia, August 1st 2017 - August 1st 2020 (dark grey: lockdown, light grey: de-escalation phases). Fig. S2. Expected and observed time series trends of daily Gonorrhoea reported confirmed cases in Catalonia, August 1st 2017 - August 1st 2020 (dark grey: lockdown, light grey: de-escalation phases). Fig. S3. Expected and observed time series trends of daily Syphilis reported confirmed cases in Catalonia, August 1st 2017 - August 1st 2020 (dark grey: lockdown, light grey: de-escalation phases). Fig. S4. Expected and observed time series trends of daily lymphogranuloma venerum (LGV) reported cases in Catalonia, August 1st 2017 - August 1st 2020 (dark grey: lockdown, light grey: de-escalation phases).
  11 in total

1.  Is COVID-19 affecting the epidemiology of STIs? The experience of syphilis in Rome.

Authors:  Alessandra Latini; Francesca Magri; Maria Gabriella Donà; Massimo Giuliani; Antonio Cristaudo; Mauro Zaccarelli
Journal:  Sex Transm Infect       Date:  2020-07-27       Impact factor: 3.519

Review 2.  Emerging and Reemerging Sexually Transmitted Infections.

Authors:  Deborah A Williamson; Marcus Y Chen
Journal:  N Engl J Med       Date:  2020-05-21       Impact factor: 91.245

3.  Physical Distancing Due to COVID-19 Disrupts Sexual Behaviors Among Gay and Bisexual Men in Australia: Implications for Trends in HIV and Other Sexually Transmissible Infections.

Authors:  Mohamed A Hammoud; Lisa Maher; Martin Holt; Louisa Degenhardt; Fengyi Jin; Dean Murphy; Benjamin Bavinton; Andrew Grulich; Toby Lea; Bridget Haire; Adam Bourne; Peter Saxton; Stefanie Vaccher; Jeanne Ellard; Brent Mackie; Colin Batrouney; Nicky Bath; Garrett Prestage
Journal:  J Acquir Immune Defic Syndr       Date:  2020-11-01       Impact factor: 3.731

4.  Decreases in Reported Sexually Transmitted Infections During the Time of COVID-19 in King County, WA: Decreased Transmission or Screening?

Authors:  Anna Berzkalns; Christina S Thibault; Lindley A Barbee; Matthew R Golden; Christine Khosropour; Roxanne P Kerani
Journal:  Sex Transm Dis       Date:  2021-08-01       Impact factor: 2.830

5.  Sexual and reproductive health (SRH): a key issue in the emergency response to the coronavirus disease (COVID- 19) outbreak.

Authors:  Kun Tang; Junjian Gaoshan; Babatunde Ahonsi; Moazzam Ali; Mercedes Bonet; Nathalie Broutet; Edna Kara; Caron Kim; Anna Thorson; Soe Soe Thwin
Journal:  Reprod Health       Date:  2020-04-23       Impact factor: 3.223

6.  Characterizing the Impact of COVID-19 on Men Who Have Sex with Men Across the United States in April, 2020.

Authors:  Travis H Sanchez; Maria Zlotorzynska; Mona Rai; Stefan D Baral
Journal:  AIDS Behav       Date:  2020-07

7.  Sexually Transmitted Infection Diagnoses and Access to a Sexual Health Service Before and After the National Lockdown for COVID-19 in Melbourne, Australia.

Authors:  Eric P F Chow; Jane S Hocking; Jason J Ong; Tiffany R Phillips; Christopher K Fairley
Journal:  Open Forum Infect Dis       Date:  2020-11-02       Impact factor: 3.835

8.  The Impacts of Isolation Measures Against SARS-CoV-2 Infection on Sexual Health.

Authors:  Miguel Alpalhão; Paulo Filipe
Journal:  AIDS Behav       Date:  2020-08

9.  STIs and the COVID-19 pandemic: the lockdown does not stop sexual infections.

Authors:  R Balestri; M Magnano; L Rizzoli; S D Infusino; F Urbani; G Rech
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-27       Impact factor: 6.166

10.  Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020.

Authors:  Daniel Simões; Annemarie Rinder Stengaard; Lauren Combs; Dorthe Raben
Journal:  Euro Surveill       Date:  2020-11
View more
  8 in total

1.  Rising syphilis rates in Canada, 2011-2020.

Authors:  Josephine Aho; Cassandra Lybeck; Ashorkor Tetteh; Carmen Issa; Fiona Kouyoumdjian; Jason Wong; Alexandrea Anderson; Nashira Popovic
Journal:  Can Commun Dis Rep       Date:  2022-02-24

2.  Use of healthcare reimbursement data to monitor bacterial sexually transmitted infection testing in France, 2006 to 2020.

Authors:  Delphine Viriot; Etienne Lucas; Bertille de Barbeyrac; Cécile Bébéar; Sébastien Fouéré; Nicolas Dupin; Antoine Bertolotti; Béatrice Berçot; Charles Cazanave; Gilles Delmas; Josiane Pillonel; Florence Lot; Ndeindo Ndeikoundam Ngangro
Journal:  Euro Surveill       Date:  2022-09

3.  "Compared to COVID, HIV Is Nothing": Exploring How Onshore East Asian and Sub-Saharan African International Students in Sydney Navigate COVID-19 versus BBVs/STIs Risk Spectrum.

Authors:  Sylvester Reuben Okeke
Journal:  Int J Environ Res Public Health       Date:  2022-05-21       Impact factor: 4.614

Review 4.  Surveillance and control of meningococcal disease in the COVID-19 era: A Global Meningococcal Initiative review.

Authors:  Mark R Alderson; Peter D Arkwright; Xilian Bai; Steve Black; Ray Borrow; Dominique A Caugant; Ener Cagri Dinleyici; Lee H Harrison; Jay Lucidarme; Lucy A McNamara; Susan Meiring; Marco A P Sáfadi; Zhujun Shao; David S Stephens; Muhamed-Kheir Taha; Julio Vazquez; Bingqing Zhu; Gmi Collaborators
Journal:  J Infect       Date:  2021-11-24       Impact factor: 6.072

5.  Eliminating Mother-to-Child Transmission of Syphilis: Chinese Practice before and during COVID-19 Pandemics.

Authors:  Fang-Zhi Du; Rui-Li Zhang; Qian-Qiu Wang
Journal:  Chin Med Sci J       Date:  2022-02-28

6.  Development and comparison of predictive models for sexually transmitted diseases-AIDS, gonorrhea, and syphilis in China, 2011-2021.

Authors:  Zhixin Zhu; Xiaoxia Zhu; Yancen Zhan; Lanfang Gu; Liang Chen; Xiuyang Li
Journal:  Front Public Health       Date:  2022-08-12

7.  The impact of COVID-19 non-pharmaceutical interventions on HIV care continuum in China: An interrupted time series analysis.

Authors:  Xinsheng Wu; Guohui Wu; Yanmin Ma; Xiaojie Huang; Yuecheng Yang; Yanshan Cai; Ganfeng Luo; Ping Ma; Ying Qiao; Yuanyi Chen; Yi-Fan Lin; Yanxiao Gao; Yuewei Zhan; Wei Song; Yingying Wang; Rugang Wang; Xuejuan Yang; Lijun Sun; Hongxia Wei; Quanmin Li; Xiaoli Xin; Lijing Wang; Xicheng Wang; Ronghui Xie; Lijuan Yang; Xiaojun Meng; Jin Zhao; Linghua Li; Tong Zhang; Junjie Xu; Gengfeng Fu; Huachun Zou
Journal:  Lancet Reg Health West Pac       Date:  2022-08-10

8.  Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany.

Authors:  Daniel Schmidt; Christian Kollan; Barbara Bartmeyer; Viviane Bremer; Tim Schikowski; Martin Friebe; Sven Schellberg; Stefan Scholten; Markus Bickel; Nikola Hanhoff; Robin Rüsenberg; Knud Schewe
Journal:  Infection       Date:  2022-09-27       Impact factor: 7.455

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.